Dávila B - Search Results

1

3-H-[1,2]Dithiole as a New Anti-Trypanosoma cruzi Chemotype: Biological and Mechanism of Action Studies.

Couto M, Sánchez C, Dávila B, Machín V, Varela J, Álvarez G, Cabrera M, Celano L, Aguirre-López B, Cabrera N, de Gómez-Puyou MT, Gómez-Puyou A, Pérez-Montfort R, Cerecetto H, González M. Couto M, et al. Among authors: davila b. Molecules. 2015 Aug 12;20(8):14595-610. doi: 10.3390/molecules200814595. Molecules. 2015. PMID: 26274947 Free PMC article.

2

Carboranylanilinoquinazoline EGFR-inhibitors: toward 'lead-to-candidate' stage in the drug-development pipeline.

Couto M, Alamón C, Sánchez C, Dávila B, Fernández M, Lecot N, Cabral P, Teixidor F, Viñas C, Cerecetto H. Couto M, et al. Among authors: davila b. Future Med Chem. 2019 Sep;11(17):2273-2285. doi: 10.4155/fmc-2019-0060. Future Med Chem. 2019. PMID: 31581913

3

Sunitinib-Containing Carborane Pharmacophore with the Ability to Inhibit Tyrosine Kinases Receptors FLT3, KIT and PDGFR-β, Exhibits Powerful In Vivo Anti-Glioblastoma Activity.

Alamón C, Dávila B, García MF, Sánchez C, Kovacs M, Trias E, Barbeito L, Gabay M, Zeineh N, Gavish M, Teixidor F, Viñas C, Couto M, Cerecetto H. Alamón C, et al. Among authors: davila b. Cancers (Basel). 2020 Nov 18;12(11):3423. doi: 10.3390/cancers12113423. Cancers (Basel). 2020. PMID: 33218150 Free PMC article.

4

Development of 3D-QSAR and pharmacophoric models to design new anti-Trypanosoma cruzi agents based on 2-aryloxynaphthoquinone scaffold.

Paulino M, Espinosa-Bustos C, Bertrand J, Cabezas D, Mella J, Dávila B, Cerecetto H, Ballesteros-Casallas A, Salas CO. Paulino M, et al. Among authors: davila b. SAR QSAR Environ Res. 2022 Sep;33(9):701-728. doi: 10.1080/1062936X.2022.2120069. SAR QSAR Environ Res. 2022. PMID: 36106834

5

Development and Evaluation of 2-Amino-7-Fluorophenazine 5,10-Dioxide Polymeric Micelles as Antitumoral Agents for 4T1 Breast Cancer.

Lecot N, Dávila B, Sánchez C, Fernández M, González M, Cabral P, Cerecetto H, Glisoni R. Lecot N, et al. Among authors: davila b. Polymers (Basel). 2021 Dec 25;14(1):71. doi: 10.3390/polym14010071. Polymers (Basel). 2021. PMID: 35012094 Free PMC article.

6

[Electromagnetic shock wave lithotripsy plus bile acids for the treatment of gallblader stones: results and perspectives from the first 57 patients].

Uribe M, Sánchez JM, Tielve JM, Dávila B, Gurza L, Bosques F, Kettenhofen W, Sánchez C, Castorena G. Uribe M, et al. Among authors: davila b. Rev Invest Clin. 1990 Jul;42 Suppl:71-4. Rev Invest Clin. 1990. PMID: 19256139 Spanish.

7

[Fragmentation of single biliary calculi with an electromagnetic generator].

Manuel Sánchez J, Méndez-Sánchez N, Bosques F, Gurza L, Dávila B, Guerrero J, Aguilar Ramírez A, Uribe M. Manuel Sánchez J, et al. Among authors: davila b. Rev Gastroenterol Mex. 1991 Jul-Sep;56(3):159-63. Rev Gastroenterol Mex. 1991. PMID: 1822011 Spanish.

8

Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study.

Heo M, Norton BL, Pericot-Valverde I, Mehta SH, Tsui JI, Taylor LE, Lum PJ, Feinberg J, Kim AY, Arnsten JH, Sprecht-Walsh S, Page K, Murray-Krezan C, Anderson J, Litwin AH; HERO Study Group. Heo M, et al. J Hepatol. 2024 May;80(5):702-713. doi: 10.1016/j.jhep.2023.12.020. Epub 2024 Jan 17. J Hepatol. 2024. PMID: 38242324

9

Optimization of the 2-arylquinazoline-4(3H)one scaffold for a selective and potent antitrypanosomal agent: modulation of the mechanism of action through chemical functionalization.

Romero AH, Aguilera E, Gotopo L, Cabrera G, Dávila B, Cerecetto H. Romero AH, et al. Among authors: davila b. RSC Med Chem. 2023 Jul 11;14(10):1992-2006. doi: 10.1039/d3md00243h. eCollection 2023 Oct 18. RSC Med Chem. 2023. PMID: 37859724

10

A Potential Boron Neutron Capture Therapy Agent Selectively Suppresses High-Grade Glioma: In Vitro and in Vivo Exploration.

Alamón C, Dávila B, García MF, Nievas S, Dagrosa MA, Thorp S, Kovacs M, Trias E, Faccio R, Gabay M, Zeineh N, Weizman A, Teixidor F, Viñas C, Gavish M, Cerecetto H, Couto M. Alamón C, et al. Among authors: davila b. Mol Pharm. 2023 May 1;20(5):2702-2713. doi: 10.1021/acs.molpharmaceut.3c00152. Epub 2023 Apr 4. Mol Pharm. 2023. PMID: 37013916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page